Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radioactive Stent for Malignant Airway Obstruction
NCT02565927Phase 2Unknown
- Sponsor
- Zhongda Hospital, Southeast University
- Start
- May 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of iodine-125 in malignant central airway obstruction (2 arms), sponsored by Zhongda Hospital, Southeast University. Primary endpoint: Diameter stenosis at 1 year. Status: unknown.
02
Drugs
iodine-125
03
Conditions
malignant central airway obstruction
Beyond the preview
Go deeper on NCT02565927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02565927.